Annual CFI
$0.00
+$29.00 K+100.00%
31 December 2023
Summary:
Verona Pharma annual cash flow from investing activities is currently $0.00, with the most recent change of +$29.00 thousand (+100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$9.71 million (-100.00%). VRNA annual CFI is now -100.00% below its all-time high of $47.31 million, reached on 31 December 2019.VRNA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
+$29.00 K+100.00%
30 September 2024
Summary:
Verona Pharma quarterly cash flow from investing activities is currently $0.00, with the most recent change of +$29.00 thousand (+100.00%) on 30 September 2024. Over the past year, it has stayed the same.VRNA quarterly CFI is now -100.00% below its all-time high of $22.57 million, reached on 30 September 2019.VRNA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$45.00 K
$0.000.00%
30 September 2024
Summary:
Verona Pharma TTM cash flow from investing activities is currently -$45.00 thousand, unchanged on 30 September 2024. Over the past year, it has dropped by -$45.00 thousand (-100.00%). VRNA TTM CFI is now -100.10% below its all-time high of $47.31 million, reached on 31 December 2019.VRNA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | 0.0% | -100.0% |
| 3 y3 years | -100.0% | +100.0% | -125.0% |
| 5 y5 years | -100.0% | -100.0% | -100.1% |
VRNA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | +100.0% | +100.0% | at low | ||
| 5 y | 5 years | -100.0% | +100.0% | -100.0% | +100.0% | -100.1% | +41.6% |
| alltime | all time | -100.0% | +100.0% | -100.0% | +100.0% | -100.1% | +99.9% |
Verona Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | -$45.00 K(0.0%) |
| June 2024 | - | -$29.00 K(+81.3%) | -$45.00 K(+181.3%) |
| Mar 2024 | - | -$16.00 K(<-9900.0%) | -$16.00 K(<-9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2023 | - | $0.00(0.0%) | -$29.00 K(0.0%) |
| Dec 2022 | -$29.00 K(+141.7%) | $0.00(0.0%) | -$29.00 K(-3.3%) |
| Sept 2022 | - | $0.00(-100.0%) | -$30.00 K(-26.8%) |
| June 2022 | - | -$29.00 K(<-9900.0%) | -$41.00 K(+241.7%) |
| Mar 2022 | - | $0.00(-100.0%) | -$12.00 K(0.0%) |
| Dec 2021 | -$12.00 K(-100.1%) | -$1000.00(-90.9%) | -$12.00 K(-40.0%) |
| Sept 2021 | - | -$11.00 K(<-9900.0%) | -$20.00 K(-74.0%) |
| June 2021 | - | $0.00(0.0%) | -$77.00 K(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) | -$77.00 K(-100.8%) |
| Dec 2020 | $9.71 M(-79.5%) | -$9000.00(-86.8%) | $9.71 M(+21.1%) |
| Sept 2020 | - | -$68.00 K(<-9900.0%) | $8.02 M(-73.8%) |
| June 2020 | - | $0.00(-100.0%) | $30.65 M(-32.4%) |
| Mar 2020 | - | $9.79 M(-674.7%) | $45.32 M(-4.2%) |
| Dec 2019 | $47.31 M | -$1.70 M(-107.5%) | $47.31 M(+6.2%) |
| Sept 2019 | - | $22.57 M(+53.9%) | $44.54 M(+319.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $14.67 M(+24.5%) | $10.62 M(-13.2%) |
| Mar 2019 | - | $11.78 M(-362.9%) | $12.24 M(+82.7%) |
| Dec 2018 | $6.70 M(-110.0%) | -$4.48 M(-60.5%) | $6.70 M(-62.2%) |
| Sept 2018 | - | -$11.34 M(-169.6%) | $17.72 M(-786.7%) |
| June 2018 | - | $16.29 M(+161.0%) | -$2.58 M(-95.7%) |
| Mar 2018 | - | $6.24 M(-4.6%) | -$60.57 M(-9.4%) |
| Dec 2017 | -$66.85 M(>+9900.0%) | $6.54 M(-120.7%) | -$66.85 M(-8.9%) |
| Sept 2017 | - | -$31.64 M(-24.1%) | -$73.39 M(+75.8%) |
| June 2017 | - | -$41.70 M(>+9900.0%) | -$41.75 M(>+9900.0%) |
| Mar 2017 | - | -$43.70 K | -$43.70 K |
| Dec 2016 | -$50.60 K(-62.9%) | - | - |
| Dec 2015 | -$136.30 K(-55.4%) | - | - |
| Dec 2014 | -$305.70 K(+76.6%) | - | - |
| Dec 2013 | -$173.10 K(+97.2%) | - | - |
| Dec 2012 | -$87.80 K(+130.4%) | - | - |
| Dec 2011 | -$38.10 K(-39.8%) | - | - |
| Dec 2010 | -$63.30 K(+160.5%) | - | - |
| Dec 2009 | -$24.30 K(-114.3%) | - | - |
| Dec 2008 | $169.90 K(-93.9%) | - | - |
| Dec 2007 | $2.76 M(-210.5%) | - | - |
| Dec 2006 | -$2.50 M(-5480.4%) | - | - |
| Dec 2005 | $46.50 K | - | - |
FAQ
- What is Verona Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for Verona Pharma?
- What is Verona Pharma annual CFI year-on-year change?
- What is Verona Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Verona Pharma?
- What is Verona Pharma quarterly CFI year-on-year change?
- What is Verona Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Verona Pharma?
- What is Verona Pharma TTM CFI year-on-year change?
What is Verona Pharma annual cash flow from investing activities?
The current annual CFI of VRNA is $0.00
What is the all time high annual CFI for Verona Pharma?
Verona Pharma all-time high annual cash flow from investing activities is $47.31 M
What is Verona Pharma annual CFI year-on-year change?
Over the past year, VRNA annual cash flow from investing activities has changed by +$29.00 K (+100.00%)
What is Verona Pharma quarterly cash flow from investing activities?
The current quarterly CFI of VRNA is $0.00
What is the all time high quarterly CFI for Verona Pharma?
Verona Pharma all-time high quarterly cash flow from investing activities is $22.57 M
What is Verona Pharma quarterly CFI year-on-year change?
Over the past year, VRNA quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Verona Pharma TTM cash flow from investing activities?
The current TTM CFI of VRNA is -$45.00 K
What is the all time high TTM CFI for Verona Pharma?
Verona Pharma all-time high TTM cash flow from investing activities is $47.31 M
What is Verona Pharma TTM CFI year-on-year change?
Over the past year, VRNA TTM cash flow from investing activities has changed by -$45.00 K (-100.00%)